• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconDaraprim

Daraprim

Former KaloBios Pharmaceuticals Chief Executive Officer Martin Shkreli Court Appearance
HealthMartin Shkreli Seriously Didn’t Care About Jacking Up Drug Prices
By Laura LorenzettiFebruary 3, 2016
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
LeadershipMartin Shkreli Asks Court to Consider Blocking Subpoena
By ReutersJanuary 23, 2016
Turing Pharmaceutical CEO Martin Shkreli Arrested For Securities Fraud
FinanceHere’s How Much Martin Shkreli Is Actually Worth
By Jen WiecznerJanuary 8, 2016
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
HealthMartin Shkreli’s Twitter Account Hacked
By Reuters and Aaron TaskDecember 20, 2015
US-CRIME-JUSTICE-SHKRELI
HealthTuring Replaces Martin Shkreli with Interim CEO
By Laura LorenzettiDecember 18, 2015
US-CRIME-JUSTICE-SHKRELI
HealthMartin Shkreli Is Reportedly Stepping Down as Turing CEO
By Benjamin SnyderDecember 18, 2015
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
LeadershipMartin Shkreli’s 15 Minutes Are Up
By Geoff ColvinDecember 18, 2015
Turing Pharmaceutical CEO Martin Shkreli Arrested For Securities Fraud
HealthHow Pharmacies Are Dealing with Daraprim After Martin Shkreli’s Arrest
By ReutersDecember 18, 2015
Turing Pharmaceutical CEO Martin Shkreli Arrested For Securities Fraud
FinancePharma CEO Martin Shkreli Arrested for Securities Fraud
By Geoffrey SmithDecember 17, 2015
MSMB Capital Management CIO Martin Shkreli
HealthExpress Scripts is Taking on Turing Pharmaceuticals’ 5,000% Price Hike
By Claire GrodenDecember 1, 2015
MSMB Capital Management CIO Martin Shkreli
HealthTuring Offers Hospitals Discounts on Daraprim Price
By Laura LorenzettiNovember 25, 2015
MSMB Capital Management CIO Martin Shkreli
HealthTuring Says it Will Lower Daraprim Price by the End of the Year
By Laura LorenzettiNovember 4, 2015
RetailWhy the drug price scandal won’t be enough to keep down prices
By Laura LorenzettiOctober 26, 2015
Imprimis Turing Drug
HealthThis company is offering a $1 alternative to Turing’s $750 drug
By Laura LorenzettiOctober 23, 2015
MSMB Capital Management CIO Martin Shkreli
HealthThis super-expensive drug is getting a $1 rival
By Benjamin SnyderOctober 23, 2015
1
  • 1
  • 2
2
Most Popular
Economy
Trump may have shot himself in the foot at the Fed, as Powell could stay on while Miran resigns from White House postAn image of a popular article
By Eleanor PringleFebruary 4, 2026
Politics
Peter Thiel warns the Antichrist and apocalypse are linked to the ‘end of modernity’ currently happening—and cites Greta Thunberg as a driving exampleAn image of a popular article
By Nick LichtenbergFebruary 4, 2026
Success
After decades in the music industry, Pharrell Williams admits he never stops working: ‘If you do what you love everyday, you’ll get paid for free'An image of a popular article
By Emma BurleighFebruary 3, 2026
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.